Cargando…
Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma
Although several biomarkers can be used to distinguish cholangiocarcinoma (CCA) from healthy controls, differentiating the disease from benign biliary disease (BBD) or pancreatic cancer (PC) is a challenge. CCA biomarkers are associated with low specificity or have not been validated in relation to...
Autores principales: | Song, Won-Suk, Park, Hae-Min, Ha, Jung Min, Shin, Sung Gyu, Park, Han-Gyu, Kim, Joonwon, Zhang, Tianzi, Ahn, Da-Hee, Kim, Sung-Min, Yang, Yung-Hun, Jeong, Jae Hyun, Theberge, Ashleigh B., Kim, Byung-Gee, Lee, Jong Kyun, Kim, Yun-Gon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056462/ https://www.ncbi.nlm.nih.gov/pubmed/30038332 http://dx.doi.org/10.1038/s41598-018-29445-z |
Ejemplares similares
-
Metabolomic and lipidomic studies on the intervention of taurochenodeoxycholic acid in mice with hyperlipidemia
por: Cui, Na, et al.
Publicado: (2023) -
Transcriptome investigation of anti‐inflammation and immuno‐regulation mechanism of taurochenodeoxycholic acid
por: Bao, Lige, et al.
Publicado: (2021) -
Preparation and Evaluation of Mucus-Penetrating Inhalable Microparticles of Tiotropium Bromide Containing Sodium Glycocholate
por: Kwon, Yong-Bin, et al.
Publicado: (2022) -
Taurochenodeoxycholic Acid Inhibited AP-1 Activation via Stimulating Glucocorticoid Receptor
por: Li, Lei, et al.
Publicado: (2019) -
Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5
por: Qi, Youchao, et al.
Publicado: (2021)